Resultados de procura - Ivan M. Robbins

Limitar resultados
  1. 1
    Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation

    Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation por Anna R. Hemnes, Ivan M. Robbins

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Physical Activity Limitation as Measured by Accelerometry in Pulmonary Arterial Hypertension

    Physical Activity Limitation as Measured by Accelerometry in Pulmonary Arterial Hypertension por Meredith E. Pugh, Maciej S. Buchowski, Ivan M. Robbins, John H. Newman, Anna R. Hemnes

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Use of Pulmonary Arterial Hypertension–Approved Therapy in the Treatment of Non–Group 1 Pulmonary Hypertension at US Referral Centers

    Use of Pulmonary Arterial Hypertension–Approved Therapy in the Treatment of Non–Group 1 Pulmonary Hypertension at US Referral Centers por Aaron W. Trammell, Meredith E. Pugh, John H. Newman, Anna R. Hemnes, Ivan M. Robbins

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Causes of Pulmonary Hypertension in the Elderly

    Causes of Pulmonary Hypertension in the Elderly por Meredith E. Pugh, Lakshmi Sivarajan, Li Wang, Ivan M. Robbins, John H. Newman, Anna R. Hemnes

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Unrecognized glucose intolerance is common in pulmonary arterial hypertension

    Unrecognized glucose intolerance is common in pulmonary arterial hypertension por Meredith E. Pugh, Ivan M. Robbins, Todd W. Rice, James West, John H. Newman, Anna R. Hemnes

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Pathologic assessment of vasculopathies in pulmonary hypertension

    Pathologic assessment of vasculopathies in pulmonary hypertension por Giuseppe G. Pietra, Frédérique Capron, Susan Stewart, Ornella Leone, Marc Humbert, Ivan M. Robbins, Lynne Reid, Rubin M. Tuder

    Publicado 2004
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Impact of Diabetes on Survival and Right Ventricular Compensation in Pulmonary Arterial Hypertension

    Impact of Diabetes on Survival and Right Ventricular Compensation in Pulmonary Arterial Hypertension por Levi Benson, Evan L. Brittain, Meredith E. Pugh, Eric D. Austin, Kelly Fox, Lisa Wheeler, Ivan M. Robbins, Anna R. Hemnes

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation

    Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation por Ivan M. Robbins, Edward V. Colvin, Thomas P. Doyle, W. Evans Kemp, James E. Loyd, William McMahon, G. Neal Kay

    Publicado 1998
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension

    T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension por Eric D. Austin, Michael T. Rock, Claudio A. Mosse, Cindy L. Vnencak‐Jones, Sandra Yoder, Ivan M. Robbins, James E. Loyd, Barbara Meyrick

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension

    Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension por Paul Bresser, Peter F. Fedullo, William R. Auger, Richard N. Channick, Ivan M. Robbins, Kim M. Kerr, S. W. Jamieson, Lewis J. Rubin

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension

    High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension por Ivan M. Robbins, Anna R. Hemnes, Meredith E. Pugh, Evan L. Brittain, David Zhao, Robert N. Piana, Pete Fong, John H. Newman

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Association of the Metabolic Syndrome With Pulmonary Venous Hypertension

    Association of the Metabolic Syndrome With Pulmonary Venous Hypertension por Ivan M. Robbins, John H. Newman, Roger F. Johnson, Anna R. Hemnes, Richard D. Fremont, Robert N. Piana, David Zhao, Daniel W. Byrne

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension

    Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hyperten... por Raymond L. Benza, Werner Seeger, Vallerie V. McLaughlin, Richard N. Channick, Robert Voswinckel, Victor F. Tapson, Ivan M. Robbins, Horst Olschewski, Lewis J. Rubin

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease

    ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease por Christopher Lathen, Yu Zhang, Jennifer Chow, Martanday Singh, Grace Lin, Vishal Nigam, Yasser A. Ashraf, Jason X.‐J. Yuan, Ivan M. Robbins, Patricia A. Thistlethwaite

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2

    Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2 por Marc Humbert, Robyn J. Barst, Ivan M. Robbins, Richard N. Channick, Nazzareno Galiè, A. Boonstra, Leona J. Rubin, Evelyn M. Horn, A. Manes, G. Simonneau

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension

    Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension por Vallerie V. McLaughlin, Raymond L. Benza, Lewis J. Rubin, Richard N. Channick, Robert Voswinckel, Victor F. Tapson, Ivan M. Robbins, Horst Olschewski, Melvyn Rubenfire, Werner Seeger

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Longitudinal Analysis Casts Doubt on the Presence of Genetic Anticipation in Heritable Pulmonary Arterial Hypertension

    Longitudinal Analysis Casts Doubt on the Presence of Genetic Anticipation in Heritable Pulmonary Arterial Hypertension por Emma K. Larkin, John H. Newman, Eric D. Austin, Anna R. Hemnes, Lisa Wheeler, Ivan M. Robbins, James West, John A. Phillips, Rizwan Hamid, James E. Loyd

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

    Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension por Eric D. Austin, John A. Phillips, Joy D. Cogan, Rizwan Hamid, Chang Yu, Krista C. Stanton, Charles Phillips, Lisa Wheeler, Ivan M. Robbins, John H. Newman, James E. Loyd

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension

    Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension por Tufik R. Assad, Bradley A. Maron, Ivan M. Robbins, Meng Xu, Shi Huang, Frank E. Harrell, Eric Farber‐Eger, Quinn S. Wells, Gaurav Choudhary, Anna R. Hemnes, Evan L. Brittain

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension

    Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension por James P. Maloney, Robert S. Stearman, Todd Bull, David W. Calabrese, Megan L. Tripp-Addison, Marilee J. Wick, Ulrich Broeckel, Ivan M. Robbins, Lisa Wheeler, Joy D. Cogan, James E. Loyd

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: